Researchers at Wayne State University School of Medicine have published a study in the journal iScience, shedding light on the potential treatment targets for eye abnormalities caused by the Zika virus (ZIKV) infection during pregnancy.
Provectus Secures Global Licensing Agreement for Eye Infection TreatmentMar 28, 2024Provectus Biopharmaceuticals has signed an exclusive global licensing agreement with the University of Miami to harness the University’s pioneering photodynamic antimicrobial therapy for combating (acanthamoeba) eye infections.
Don't Miss Out: ASCRS Congress 2024 Kicks Off This April 5-8Mar 28, 2024From April 5 to 8, 2024, the American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting is set to take place in Boston, USA, at the Boston Convention & Exhibition Center.
ABVC BioPharma Announces Global Licensing Agreement with ForSeeCon Mar 28, 2024ABVC BioPharma, Inc. has entered into a significant global licensing agreement with ForSeeCon Eye Corporation, marking a pivotal moment for the clinical-stage biopharmaceutical company known for its developments in ophthalmology, CNS, and oncology.
Ophthalmic Research News
New Study Opens Pathways for Treating Zika Virus-Induced Eye AbnormalitiesMar 29, 2024Researchers at Wayne State University School of Medicine have published a study in the journal iScience, shedding light on the potential treatment targets for eye abnormalities caused by the Zika virus (ZIKV) infection during pregnancy.
First Canadian Patient Dosed in Aurion’s Cell Therapy Trial for Corneal EdemaMar 29, 2024Aurion Biotech recently administered its novel cell therapy, AURN001, to the first Canadian participant in the ABA-1, CLARA phase 1/2 clinical trial, targeting the treatment of corneal edema caused by corneal endothelial dysfunction.
The Serious Impact of Smoking on Your Eye Health Mar 25, 2024Smoking is widely recognized as a major health hazard, contributing to a range of systemic diseases, including lung cancer, heart disease, stroke as well as eye diseases.